Transcarent Raises $126M, Valued at $2.2B, Eyes AI Expansion and Acquisitions

May 2, 2024, 03:30 PM

Transcarent, a health tech unicorn co-founded by Glen Tullman, has successfully raised $126 million in a Series D funding round. The round was led by General Catalyst and 7wireVentures. This new influx of capital, which values Transcarent at $2.2 billion, is earmarked for advancing AI projects and strategic acquisitions. The funding signifies a positive shift in the health tech funding landscape, suggesting a market rebound.